AEON Biopharma, Inc. (AEON)
NYSE: AEON · Pharmaceutical Preparations · Irvine, CA · filing with the SEC since 2020
Filings
286 filings since 2017 beside 77 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Oct 26, 2026.
Filings a yearinsider forms included
12421115796756
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Apr 3, 2026.Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Mar 9, 2026.Warning not to rely on past financial statements (8-K item 4.02): 2 times in the last 36 months, the newest May 3, 2024.SEC letters: 18 in the last 36 months, the newest Feb 12, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 30, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Aug 12, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 3, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jul 15, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Jul 13, 2026
Jan 21, 2026
8-K items 3.02, 5.02, 5.07, 7.01, 8.01, 9.01
Shares sold without registration; Officer or director change; Shareholder vote; Investor disclosure (Regulation FD); Other event · Current report
40 of 286 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.